Idiopathic hypereosinophilic syndrome revealed by central nervous system dysfunction

Acta Neurologica Belgica

Volumn 96, Issue 2, 1996, Pages 137-140

  Lebbink, J ^a   Laterre, E C ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Encephalopathy; Hypereosinophilia; Vasculitis

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE;

ARTICLE; BRAIN DISEASE; CASE REPORT; DRUG COMBINATION; FEMALE; HUMAN; HYPEREOSINOPHILIC SYNDROME; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING;

ANTI-INFLAMMATORY AGENTS; BRAIN DISEASES; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPEREOSINOPHILIC SYNDROME; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE IMAGING; METHYLPREDNISOLONE; MIDDLE AGED;

EID: 0030162528     PISSN: 03009009     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. BOCKENSTEDT P. L., SANTIGNA J. T., BOLLING S. F. Alpha-Interferon treatment for idiopathic hypereosinophilic syndrome. Am. J. Hematol., 1994, 45 : 248-251.
2. CARLSON M., OBERG G., PETERSON C., VENGE P. Releasability of human hypereosinophilic eosinophils is related to the density of the cells. Br. J. Haematol., 1994, 86 : 41-47.
3. CHAINE G., DAVIES, J., KOHNER E. M., HWARTH S., SPRY, C. J. F. Ophtalmologic abnormalities in the hypereosinophilic syndrome. Ophtalmology, 1982, 89 : 1348-1356.
4. CHUSID M. J., DALE C. D., WEST B. C., WOLFF S. M. The hypereosinophilic syndrome : analysis of 14 cases with review of the literature. Medicine, 1975, 54 : 1-17.
5. DALE D. C. Leucocytosis, leukopenia and eosinophilia. In : Wilson J. D. et at., eds. Harrison's principles of internal medicine. 12th ed. New York ; McGraw-Hill, 1991 : 362.
6. ELLMAN L., MILLER, L., Rappeport J. Leukopheresis therapy of a hypereosinophilic disorder. J A M A, 1974, 230 : 1004-1005.
7. HARDY W. R., ANDERSON R. E. The hypereosinophilic syndromes. Ann. Intern. Med., 1968, 68 : 1220-1229.
8. KAZMIEROWSKI J. A., CHUSID M. J., PARILLO J. E., FAUCI A. S., WOLFF S. M. Dermatologic manifestations of the hypereosinophilic syndrome. Arch. Dermatol., 1978, 114 : 531-535.
9. LEFEBVRE C., BLETRY O., DEGOULET P., GUILLEVIN L., BENTATA-PESSAYRE M. et al. Facteurs pronostiques du syndrome hypereosinophilique. Ann. Med. Interne, 1989, 140 : 253-253-527.
10. MOORE P. M., HARLEY J. B., FAUCI A. S. Neurologic dysfunction in the idiopathic hypereosinophilic syndrome. Ann. Intern. Med., 1985, 102 : 109-114.
11. PARILLO J. E., FAUCI A. S., WOLFF S. M. Therapy of the hypereosinophilic syndrome. Ann. Intern. Med., 1978, 89 : 167712.
12. PARILLO J. E., BORER J. S., HENRY W. L., WOLFF S. M., FAUCI A. S. The cardiovascular manifestations of the hypereosinophilic syndrome. Am. J. Med., 1979, 67 : 572-582.
13. PRICK J. J. W., GABREËLS-FESTEN A. A. W. M., KORTEN J. J., VAN DER WIEL Th. W. M. Neurological manifestations of the hypereosinophilic syndrome (HES). Clin. Neurol. Neurosurg., 1988, 90 : 269-273.
14. SCHOOLEY R. T., PARILLO J. E., WOLFF S. M., FAUCI A. S. Management of the idiopathic hypereosinophilic syndrome. In : Mahmoud A. A. F., Austen K. F. eds. The eosinophil in health and disease. New York : Grune and Stratton, 1980 : 323-343.
15. SCHOOLEY R. T., FLAUM M. A., GRANLNICK H. R., FAUCI A. C. A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. II Clinical manifestations. Blood, 1981, 58 : 1021-1026.
16. SPRY C. J. F. The hypereosinophilic syndrome : Clinical features, laboratory findings and treatment. Allergy, 1982, 37 : 539-551.
17. SPRY C. J. F., DAVIES J., TAI P. C., OLSEN E. G. J., OAKLEY C. M. et al. Clinical features of fifteen patients with the hypereosinophilic syndrome. Quarterley J. Med., New Series L II, 1983, 205 : 1-22.
18. TAI P. C., SPRY C. J. F., OLSEN E. G. J., ACKERMAN S. J., DUNETTE S. et al. Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet, 1987, 21 : 643-647.
19. VARGA J., UITTO J., JIMENEZ S. A. The cause and pathogenesis of the eosinophilia-myalgia syndrome. Ann. Intern. Med., 1992, 112 : 140-147.
20. WEAVER D. F., HEFFERMAN L. P., PURDY R. A., ING V. W. Eosinophilinduced neurotoxicity : axonal neuropathy, cerebral infarction and dementia. Neurology, 1988, 38 : 144-146.
21. ZIELINSKI R. M., LAWRENCE W. D. Interferon-α for the hypereosinophilic syndrome. Ann. Int. Med., 1990, 113 : 716-717.